KUALA LUMPUR (March 2): Eye specialist service provider Optimax Holdings Bhd (KL:OPTIMAX) said in a press statement on Monday that it has obtained approval from the Ministry of Health to offer ear, nose and throat (ENT) services at its flagship ambulatory care centre Optimax Specialist Centre at the Atria Shopping Gallery, Selangor.
The centre, which started operations in the second half of financial year 2024 (FY2024) is already self-sustaining, according to the company’s FY2024 annual report.
The licence allows the group to expand its healthcare offerings by leveraging its existing facilities to deliver comprehensive ENT diagnostic and treatment services, and appointing experienced ENT specialists to strengthen its clinical team.
“By leveraging our existing facilities and clinical capacities, we are able to expand our range of services while upholding the high standards of care and patient safety that our patients expect from Optimax,” its chief executive officer Sandy Tan said in a statement.
She added that the approval reflects the company’s long-term vision to grow sustainably and to better serve its community.
The company — which has one specialist hospital, 16 ambulatory care centres and eight satellite clinics — grew FY2025 net profit by 5.6% thanks to marketing efforts and new clinic openings, which was partly offset by higher equipment maintenance costs, increased depreciation from new assets and a one-off RM0.69 million asset write-off in the fourth quarter.
According to AskEdge data, the company’s price to earnings ratio is 22.7 times, the lowest among peers and its recent historical range. Its price to net asset value ratio is 4.2 times, above most peers but at a recent low.
Optimax shares closed at 58 sen, up by half a sen from 57.5 sen on Monday, valuing the company at RM315.1 million.